Predicting the HbA 1c level following glucose-lowering interventions in individuals with HbA 1c -defined prediabetes: a post-hoc analysis from the randomized controlled PRE-D trial.

Lea BruhnDorte VistisenHanan AmadidKim K B ClemmensenKristian KarstoftMathias Ried-LarsenFrederik PerssonMarit E JørgensenCathrine Laustrup MøllerBente StallknechtKristine FærchMartin Bæk Blond

Published in: Endocrine (2023)

-defined prediabetes.

Keyphrases

phase iii
phase ii
open label
double blind
clinical trial
placebo controlled
study protocol
physical activity
blood glucose
randomized controlled trial
metabolic syndrome
type diabetes
skeletal muscle